Skip to Main Content

Author Details

Dan R Robinson
Michigan Center for Translational Pathology, University of Michigan ann arbor
2011
80
41
PMIDPaper TitleJournal TitlePublished Year
37267699Genomics driven precision oncology in advanced biliary tract cancer improves survival.Neoplasia2023
37377606Optimizing Precision Medicine for Breast Cancer Brain Metastases with Functional Drug Response Assessment.Cancer Res Commun2023
35220606Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies.J Pathol2022
35644065Homozygous ATM mutation due to germline uniparental isodisomy in patient with T acute lymphoblastic leukemia and hepatosplenic T-cell lymphoma.Cancer Genet2022
36103645Identification of Novel PGR-NR4A3 Fusion in Extraskeletal Myxoid Chondrosarcoma and Resultant Patient Benefit From Tamoxifen Therapy.JCO Precis Oncol2022
33310900Targeting transcriptional regulation of SARS-CoV-2 entry factors <i>ACE2</i> and <i>TMPRSS2</i>.Proc Natl Acad Sci U S A2021
33630025Assessment of Clinical Benefit of Integrative Genomic Profiling in Advanced Solid Tumors.JAMA Oncol2021
33753452Cancer Cell Intrinsic and Immunologic Phenotypes Determine Clinical Outcomes in Basal-like Breast Cancer.Clin Cancer Res2021
33727260A Randomized Phase II Study of Androgen Deprivation Therapy with or without Palbociclib in RB-positive Metastatic Hormone-Sensitive Prostate Cancer.Clin Cancer Res2021
34534739Identification of variant APL translocations PRKAR1A-RARα and ZBTB16-RARα (PLZF-RARα) through the MI-ONCOSEQ platform.Cancer Genet2021
34711608Transcriptional Reprogramming Differentiates Active from Inactive ESR1 Fusions in Endocrine Therapy-Refractory Metastatic Breast Cancer.Cancer Res2021
34003562Unusual clinical behavior of a very late retinoblastoma relapse in a patient with a germline RB mutation.Pediatr Blood Cancer2021
32461624Invasive squamous cell carcinomas and precursor lesions on UV-exposed epithelia demonstrate concordant genomic complexity in driver genes.Mod Pathol2020
33283137Double-Negative Prostate Cancer Masquerading as a Squamous Cancer of Unknown Primary: A Clinicopathologic and Genomic Sequencing-Based Case Study.JCO Precis Oncol2020
32605311Index of Cancer-Associated Fibroblasts Is Superior to the Epithelial-Mesenchymal Transition Score in Prognosis Prediction.Cancers (Basel)2020
33015523Clinical Sequencing of High-Grade Undifferentiated Sarcomas: A Case Series and Report of an Aggressive Primary Cardiac Tumor With Multiple Oncogenic Drivers.JCO Precis Oncol2020
32154134Mutations predictive of hyperactive Ras signaling correlate with inferior survival across high-risk pediatric acute leukemia.Transl Pediatr2020
29554022Clinical Implications of Real-time Integrative Sequencing in Management of Patients With Suspected Germline BAP1 Mutations.J Pediatr Hematol Oncol2019
31647501Integrative Exome and Transcriptome Analysis of Conjunctival Melanoma and Its Potential Application for Personalized Therapy.JAMA Ophthalmol2019
31243372Distinct structural classes of activating FOXA1 alterations in advanced prostate cancer.Nature2019
30712214Metastatic castration resistant prostate cancer with squamous cell, small cell, and sarcomatoid elements-a clinicopathologic and genomic sequencing-based discussion.Med Oncol2019
31152158Publisher Correction: The long tail of oncogenic drivers in prostate cancer.Nat Genet2019
30735636The Landscape of Circular RNA in Cancer.Cell2019
31061129Genomic correlates of clinical outcome in advanced prostate cancer.Proc Natl Acad Sci U S A2019
29144510Characterizing reduced coverage regions through comparison of exome and genome sequencing data across 10 centers.Genet Med2018
32832831Integration of Germline Pharmacogenetics Into a Tumor Sequencing Program.JCO Precis Oncol2018
32832832Clinically Integrated Sequencing Alters Therapy in Children and Young Adults With High-Risk Glial Brain Tumors.JCO Precis Oncol2018
32832830Exceptional Response to Cabozantinib in a Patient With Multiply Relapsed Wilms Tumor.JCO Precis Oncol2018
29906450Inactivation of CDK12 Delineates a Distinct Immunogenic Class of Advanced Prostate Cancer.Cell2018
30179225Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer.J Clin Invest2018
29899824Clinical validation of the Tempus xO assay.Oncotarget2018
30382943Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancer.J Clin Invest2018
29610475The long tail of oncogenic drivers in prostate cancer.Nat Genet2018
29572239Identification of novel <i>MECOM</i> gene fusion and personalized therapeutic targets through integrative clinical sequencing in secondary acute myeloid leukemia in a patient with severe congenital neutropenia: a case report and literature review.Cold Spring Harb Mol Case Stud2018
29261439Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012.J Clin Oncol2018
29233927Comprehensive Mutation and Copy Number Profiling in Archived Circulating Breast Cancer Tumor Cells Documents Heterogeneous Resistance Mechanisms.Cancer Res2018
28860053Blood-brain barrier-adapted precision medicine therapy for pediatric brain tumors.Transl Res2017
28335073Clinical characteristics and whole exome/transcriptome sequencing of coexisting chronic myeloid leukemia and myelofibrosis.Am J Hematol2017
28450425Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition.Cancer Discov2017
28423517Next generation sequencing of extraskeletal myxoid chondrosarcoma.Oncotarget2017
29163793Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategy.Oncotarget2017
28783718Integrative clinical genomics of metastatic cancer.Nature2017
28751446Gene Copy Number Estimation from Targeted Next-Generation Sequencing of Prostate Cancer Biopsies: Analytic Validation and Clinical Qualification.Clin Cancer Res2017
28775129Comprehensive Molecular Profiling of Olfactory Neuroblastoma Identifies Potentially Targetable <i>FGFR3</i> Amplifications.Mol Cancer Res2017
27181682Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.Am J Hum Genet2016
26404914A subset of solitary fibrous tumors express nuclear PAX8 and PAX2: a potential diagnostic pitfall.Histol Histopathol2016
26261103ESR1 Mutations in Circulating Plasma Tumor DNA from Metastatic Breast Cancer Patients.Clin Cancer Res2016
27582545Characterizing and targeting PDGFRA alterations in pediatric high-grade glioma.Oncotarget2016
27392080Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.Am J Hum Genet2016
27167109A comparative assessment of clinical whole exome and transcriptome profiling across sequencing centers: implications for precision cancer medicine.Oncotarget2016
  • 1 - 50 of 80

Recommended Authors

David N Brown
Memorial Sloan Kettering Cancer Center
Career Start Year 2018
Number of shared co-authors 7
Job van Riet
Erasmus MC Cancer Institute
Career Start Year 2017
Number of shared co-authors 2
Rohan Bareja
Case Western Reserve University
Career Start Year 2017
Number of shared co-authors 25
Michael Sigouros
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2017
Number of shared co-authors 22
Pier Selenica
Memorial Sloan Kettering Cancer Center
Career Start Year 2017
Number of shared co-authors 14
Sebastian Uhrig
National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ)
Career Start Year 2016
Number of shared co-authors 1
Vincent Huang
Ontario Institute for Cancer Research
Career Start Year 2016
Number of shared co-authors 2
Zachary L Skidmore
Washington University in St. Louis School of Medicine
Career Start Year 2015
Number of shared co-authors 2
Takafumi N Yamaguchi
University of California los angeles
Career Start Year 2015
Number of shared co-authors 1
Daniel Vod??k
Institute for Cancer Research, Oslo University Hospital
Career Start Year 2014
Number of shared co-authors 3
Matti Annala
University of British Columbia
Career Start Year 2011
Number of shared co-authors 14
Emilie Lalonde
University of Pennsylvania
Career Start Year 2010
Number of shared co-authors 8
Gunes Gundem
Memorial Sloan Kettering Cancer Center
Career Start Year 2010
Number of shared co-authors 11
Charlotte K Y Ng
University of Bern
Career Start Year 2009
Number of shared co-authors 19
Raymond S Lim
Memorial Sloan Kettering Cancer Center
Career Start Year 2009
Number of shared co-authors 7
Francine B de Abreu
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 0
Alexander W Wyatt
University of British Columbia
Career Start Year 2007
Number of shared co-authors 29
Nicola Waddell
QIMR Berghofer Medical Research Institute
Career Start Year 2006
Number of shared co-authors 6
Jamie K Teer
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2005
Number of shared co-authors 3
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 17
Sherri Z Millis
Foundation Medicine Inc
Career Start Year 2003
Number of shared co-authors 2
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 12
Obi L Griffith
Washington University
Career Start Year 2003
Number of shared co-authors 16
Peter Horak
German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT)
Career Start Year 2003
Number of shared co-authors 5
Volker Endris
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2001
Number of shared co-authors 1
Luciano G Martelotto
Monash University
Career Start Year 2000
Number of shared co-authors 4
Gad Getz
Broad Institute of the Massachusetts Institute of Technology and Harvard
Career Start Year 2000
Number of shared co-authors 47
Li Ding
McDonnell Genome Institute, Washington University School of Medicine
Career Start Year 1997
Number of shared co-authors 28
Siraj M Ali
Foundation Medicine
Career Start Year 1995
Number of shared co-authors 13
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 9

Collaborators

Arul M Chinnaiyan
University of Michigan Medical School.
Co-authored papers 66
Yi-Mi Wu
University of Michigan Medical School ann arbor
Co-authored papers 55
Xuhong Cao
Michigan Center for Translational Pathology.
Co-authored papers 39
Robert J Lonigro
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 30
Pankaj Vats
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 19
Lakshmi P Kunju
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 18
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Co-authored papers 16
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Co-authored papers 16
Chandan Kumar-Sinha
Co-authored papers 16
Marcin Cieslik
Co-authored papers 13
Rajen Mody
Co-authored papers 13
Rohit Mehra
Michigan Center for Translational Pathology.
Co-authored papers 13
Saravana M Dhanasekaran
Co-authored papers 12
Johann S de Bono
The Institute for Cancer Research
Co-authored papers 12
Mark A Rubin
University of Bern
Co-authored papers 11
Peter S Nelson
Fred Hutchinson Cancer Center
Co-authored papers 11
Nallasivam Palanisamy
Vattikuti Urology Institute
Co-authored papers 11
John R Prensner
University of Michigan ann arbor
Co-authored papers 10
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 10
Susana Miranda
The Institute of Cancer Research
Co-authored papers 10
Moshe Talpaz
University of Michigan Rogel Cancer Center.
Co-authored papers 9
Eliezer M Van Allen
Dana-Farber Cancer Institute
Co-authored papers 9
Himisha Beltran
Dana-Farber Cancer Institute
Co-authored papers 9
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Co-authored papers 9
Joaquin Mateo
Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital Campus
Co-authored papers 9
Levi A Garraway
Broad Institute of Harvard and MIT
Co-authored papers 9
Charles L Sawyers
Memorial Sloan Kettering Cancer Center
Co-authored papers 8
Zafeiris Zafeiriou
Theageneion Anticancer Hospital
Co-authored papers 8
Wassim Abida
Memorial Sloan Kettering Cancer Center
Co-authored papers 8
Bruce Montgomery
Fred Hutchinson Cancer Center, University of Washington
Co-authored papers 8
Release 1.2